We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
RSLS | ReShape Lifesciences Inc | 0.46 | 0.2522 | 121.37% | 10,811,418 |
BNZI | Banzai International Inc | 0.29 | 0.1148 | 65.53% | 14,327,404 |
ASTI | Ascent Solar Technologies Inc | 0.191 | 0.0417 | 27.93% | 20,372,729 |
KA | Kineta Inc | 0.59 | 0.121 | 25.80% | 1,379 |
CCG | Cheche Group Inc | 1.63 | 0.30 | 22.56% | 413,496 |
NKGN | NKGen Biotech Inc | 1.79 | 0.29 | 19.33% | 1 |
SPRC | SciSparc Ltd | 1.30 | 0.20 | 18.18% | 21 |
MYNZ | Mainz BioMed NV | 0.8968 | 0.1368 | 18.00% | 133,701 |
GPAK | Gamer Pakistan Inc | 0.295 | 0.045 | 18.00% | 4,352 |
VBIV | VBI Vaccines Inc | 0.75 | 0.11 | 17.19% | 6 |
MBIO | Mustang Bio Inc | 0.2208 | 0.0323 | 17.14% | 3,032,228 |
Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today announced the Company has filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code in the District of Delaware to pursue a wind down of its business.
Faraday Future Intelligent Electric Inc. (“Faraday Future” or the “Company”) (NASDAQ: FFIE), a California-based global shared intelligent electric mobility ecosystem company, today announced that on May 21, 2024, it received written notice from The Nasdaq Stock Market (“Nasdaq”) indicating that the Company’s failure to timely file the Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”) could serve as an additional basis for the delisting of the Company’s securities from Nasdaq under Nasdaq Listing Rule 5250(c)(1).
MIAMI, May 28, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY; LUCYW), the developer and seller of smart eyewear, today announced that it has entered into a definitive agreement for the issuance and sale of 5,263,161 shares of its common stock at a purchase price per share of $0.475 in a registered direct offering priced at-the-market under Nasdaq rules. Additionally, in a concurrent private placement, Innovative Eyewear has also agreed to issue unregistered warrants to purchase up to 5,263,161 shares of common stock at an exercise price of $0.475 per share. The unregistered warrants will ...
SANTA CLARA, Calif., May 28, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, announced today that its board of directors has adopted bitcoin as its primary treasury reserve asset. In addition, Semler Scientific announced that it has purchased 581 bitcoins for an aggregate amount of $40 million, inclusive of fees and expenses.
Rank | Ticker | Board Name | Posts (24h) |
---|---|---|---|
LWLG | Lightwave Logic Inc | 135 | |
IGPK | Integrated Cannabis Solutions Inc | 87 | |
NB | Niocorp Developments Ltd | 29 | |
4 | NSAV | NSAV Holding Inc | 101 |
5 | CYDY | Cytodyn Inc | 38 |
6 | EPAZ | Epazz Inc | 31 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 67,835.66 | -455.13 | -0.67% | 1.33T | 3,775,646,696 |
ETH | Ethereum | 3,802.58 | -37.70 | -0.98% | 456.91B | 3,146,035,153 |
USDT | Tether USD | 0.99906 | 0.00008 | 0.01% | 97.75B | 298,592,111 |
BNB | Binance Coin | 598.60 | -2.36 | -0.39% | 94.53B | 191,311,662 |
SOL | Solana | 168.78 | 0.210 | 0.12% | 74.35B | 1,051,562,435 |
STETH | stETH | 3,778.80 | -60.71 | -1.58% | 37.29B | 11,451,339 |
XRP | Ripple | 0.5291 | 0.0009 | 0.17% | 28.86B | 248,430,976 |
USDC | USD Coin | 0.99975 | -0.00025 | -0.02% | 28.07B | 1,016,747,959 |
DOGE | Dogecoin | 0.16429 | -0.00056 | -0.34% | 23.56B | 475,450,084 |
TONCOIN | Wrapped TON Coin | 6.45 | 0.013602 | 0.21% | 22.61B | 51,822,640 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions